Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids
Inadequate immunomodulatory potency of mesenchymal stem cells (MSC) may limit their therapeutic efficacy. We report glucocorticoid steroids augment MSC expression and activity of indoleamine-2,3-dioxygenase (IDO), a primary mediator of MSC immunomodulatory function. This effect depends on signaling...
Main Authors: | Ankrum, James Allen, Dastidar, Riddhi G., Ong, Joon Faii, Levy, Oren, Karp, Jeffrey Michael |
---|---|
Other Authors: | Harvard University--MIT Division of Health Sciences and Technology |
Format: | Article |
Language: | en_US |
Published: |
Nature Publishing Group
2014
|
Online Access: | http://hdl.handle.net/1721.1/88230 https://orcid.org/0000-0003-3959-6158 |
Similar Items
-
A microparticle engineering approach to enhance the potency of mesenchymal stem cells
by: Ankrum, James Allen
Published: (2014) -
Harnessing the Mesenchymal Stem Cell Secretome for the Treatment of Cardiovascular Disease
by: Ranganath, Sudhir H., et al.
Published: (2014) -
Quantification of Mesenchymal Stem Cell (MSC) Delivery to a Target Site Using In Vivo Confocal Microscopy
by: Mortensen, Luke J., et al.
Published: (2014) -
Controlled Inhibition of the Mesenchymal Stromal Cell Pro-inflammatory Secretome via Microparticle Engineering
by: Ranganath, Sudhir H., et al.
Published: (2017) -
A cell rolling cytometer reveals the correlation between mesenchymal stem cell dynamic adhesion and differentiation state
by: Choi, Sungyoung, et al.
Published: (2015)